The New Offensive on Alzheimer's Disease: Stop it Before it Starts
The announcement came the day before Thanksgiving, but there was nothing in it to be thankful for: An experimental Alzheimer's drug many thought would slow the disease's steady cognitive decline had failed to make a significant difference in a massive trial of people with early signs of the illness.
Marty Reiswig took the news hard. "I was just sad," he says. "I was really hopeful that it would be life-changing for us."
Reiswig doesn't have Alzheimer's disease--he's a 38-year-old rea...